Ocular Therapeutix, Inc. (OCUL)
11.12
-0.30
(-2.67%)
USD |
NASDAQ |
Jan 22, 16:00
11.13
+0.02
(+0.13%)
After-Hours: 16:46
Ocular Therapeutix Market Cap: 2.368B for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 135.35B |
| Alnylam Pharmaceuticals, Inc. | 48.86B |
| Dynavax Technologies Corp. | 1.838B |
| Vertex Pharmaceuticals, Inc. | 118.57B |
| Krystal Biotech, Inc. | 8.385B |
Market Cap Related Metrics
| PS Ratio | 34.57 |
| PEG Ratio | -0.8759 |
| Price to Book Value | 9.170 |
| Price | 11.12 |
| Earnings Yield | -12.92% |
| PEGY Ratio | -0.8759 |